Douglas Lorne Arnold - Publications

Affiliations: 
Department of Neurology and Neurosurgery McGill University (Montreal Neurological Institute) 

130 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Colato E, Prados F, Stutters J, Bianchi A, Narayanan S, Arnold DL, Wheeler-Kingshott C, Barkhof F, Ciccarelli O, Chard DT, Eshaghi A. Networks of microstructural damage predict disability in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 37468305 DOI: 10.1136/jnnp-2022-330203  0.559
2023 Fadda G, Cardenas de la Parra A, O'Mahony J, Waters P, Yeh EA, Bar-Or A, Marrie RA, Narayanan S, Arnold D, Collins DL, Banwell B. Deviation From Normative Whole Brain and Deep Gray Matter Growth in Children With MOGAD, MS, and Monophasic Seronegative Demyelination. Neurology. PMID 37258297 DOI: 10.1212/WNL.0000000000207429  0.663
2023 Elliott C, Rudko DA, Arnold DL, Fetco D, Elkady AM, Araujo D, Zhu B, Gafson A, Tian Z, Belachew S, Bradley DP, Fisher E. Lesion-level correspondence and longitudinal properties of paramagnetic rim and slowly expanding lesions in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231162262. PMID 37036134 DOI: 10.1177/13524585231162262  0.754
2022 Longoni G, Martinez Chavez E, Young K, Brown RA, Bells S, Fetco D, Kim L, Grover SA, Costello F, Reginald A, Bar-Or A, Marrie RA, Arnold DL, Narayanan S, Branson HM, et al. Magnetization transfer saturation reveals subclinical optic nerve injury in pediatric-onset multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221137500. PMID 36545918 DOI: 10.1177/13524585221137500  0.617
2022 Caba B, Cafaro A, Lombard A, Arnold DL, Elliott C, Liu D, Jiang X, Gafson A, Fisher E, Belachew SM, Paragios N. Single-timepoint low-dimensional characterization and classification of acute versus chronic multiple sclerosis lesions using machine learning. Neuroimage. 265: 119787. PMID 36473647 DOI: 10.1016/j.neuroimage.2022.119787  0.39
2022 Filippi M, Preziosa P, Arnold DL, Barkhof F, Harrison DM, Maggi P, Mainero C, Montalban X, Sechi E, Weinshenker BG, Rocca MA. Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective. Journal of Neurology. PMID 36427168 DOI: 10.1007/s00415-022-11488-y  0.371
2022 Tagge IJ, Leppert IR, Fetco D, Campbell JS, Rudko DA, Brown RA, Stikov N, Pike GB, Giacomini PS, Arnold DL, Narayanan S. Permanent tissue damage in multiple sclerosis lesions is associated with reduced pre-lesion myelin and axon volume fractions. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221110585. PMID 35903888 DOI: 10.1177/13524585221110585  0.817
2022 Beynon V, George IC, Elliott C, Arnold DL, Ke J, Chen H, Zhu L, Ke C, Giovannoni G, Scaramozza M, Campbell N, Bradley DP, Franchimont N, Gafson A, Belachew S. Chronic lesion activity and disability progression in secondary progressive multiple sclerosis. Bmj Neurology Open. 4: e000240. PMID 35720980 DOI: 10.1136/bmjno-2021-000240  0.391
2022 Fadda G, Waters P, Woodhall M, Brown RA, O'Mahony J, Castro DA, Longoni G, Yeh EA, Marrie RA, Arnold DL, Banwell B, Bar-Or A. Serum MOG-IgG in children meeting multiple sclerosis diagnostic criteria. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221093789. PMID 35581944 DOI: 10.1177/13524585221093789  0.321
2022 Bells S, Longoni G, Berenbaum T, de Medeiros CB, Narayanan S, Banwell BL, Arnold DL, Mabbott DJ, Ann Yeh E. Patterns of white and gray structural abnormality associated with paediatric demyelinating disorders. Neuroimage. Clinical. 34: 103001. PMID 35381508 DOI: 10.1016/j.nicl.2022.103001  0.671
2022 Cree BA, Arnold DL, Fox RJ, Gold R, Vermersch P, Benedict RH, Bar-Or A, Piani-Meier D, Rouyrre N, Ritter S, Kilaru A, Karlsson G, Giovannoni G, Kappos L. Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221083194. PMID 35380078 DOI: 10.1177/13524585221083194  0.34
2022 Nakamura K, Mokliatchouk O, Arnold DL, Yousry TA, Kappos L, Richert N, Ayling-Rouse K, Miller C, Fisher E. Effects of Dimethyl Fumarate on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: Pooled Analysis Phase 3 DEFINE and CONFIRM Studies. Frontiers in Neurology. 13: 809273. PMID 35370887 DOI: 10.3389/fneur.2022.809273  0.359
2022 Arnold DL, Piani-Meier D, Bar-Or A, Benedict RH, Cree BA, Giovannoni G, Gold R, Vermersch P, Arnould S, Dahlke F, Hach T, Ritter S, Karlsson G, Kappos L, Fox RJ. Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221076717. PMID 35261318 DOI: 10.1177/13524585221076717  0.361
2022 Lublin FD, Häring DA, Ganjgahi H, Ocampo A, Hatami F, Čuklina J, Aarden P, Dahlke F, Arnold DL, Wiendl H, Chitnis T, Nichols TE, Kieseier BC, Bermel RA. How patients with multiple sclerosis acquire disability. Brain : a Journal of Neurology. PMID 35104840 DOI: 10.1093/brain/awac016  0.319
2021 Mirza AI, Zhu F, Knox N, Forbes JD, Van Domselaar G, Bernstein CN, Graham M, Marrie RA, Hart J, Yeh EA, Arnold D, Bar-Or A, O'Mahony J, Zhao Y, Hsiao W, et al. Metagenomic Analysis of the Pediatric-Onset Multiple Sclerosis Gut Microbiome. Neurology. PMID 34937787 DOI: 10.1212/WNL.0000000000013245  0.32
2021 Dadar M, Mahmoud S, Narayanan S, Collins LD, Arnold DL, Maranzano J. Diffusely abnormal white matter converts to T2 lesion volume in the absence of MRI-detectable acute inflammation. Brain : a Journal of Neurology. PMID 34927199 DOI: 10.1093/brain/awab448  0.664
2021 Tremlett H, Zhu F, Arnold D, Bar-Or A, Bernstein CN, Bonner C, Forbes JD, Graham M, Hart J, Knox NC, Marrie RA, Mirza AI, O'Mahony J, Van Domselaar G, Yeh EA, et al. The gut microbiota in pediatric multiple sclerosis and demyelinating syndromes. Annals of Clinical and Translational Neurology. 8: 2252-2269. PMID 34889081 DOI: 10.1002/acn3.51476  0.342
2021 De Somma E, O'Mahony J, Brown RA, Brooks BL, Yeh EA, Cardenas de La Parra A, Arnold D, Collins DL, Maranzano J, Narayanan S, Marrie RA, Bar-Or A, Banwell B, Till C. Disrupted cognitive development following pediatric acquired demyelinating syndromes: a longitudinal study. Child Neuropsychology : a Journal On Normal and Abnormal Development in Childhood and Adolescence. 1-22. PMID 34872458 DOI: 10.1080/09297049.2021.2002289  0.626
2021 Elkady AM, Wu Z, Leppert IR, Arnold DL, Narayanan S, Rudko DA. Assessing the differential sensitivities of wave-CAIPI ViSTa myelin water fraction and magnetization transfer saturation for efficiently quantifying tissue damage in MS. Multiple Sclerosis and Related Disorders. 56: 103309. PMID 34688179 DOI: 10.1016/j.msard.2021.103309  0.82
2021 Elliott C, Momayyezsiahkal P, Arnold DL, Liu D, Ke J, Zhu L, Zhu B, George IC, Bradley DP, Fisher E, Cahir-McFarland E, Stys PK, Geurts JJG, Franchimont N, Gafson A, et al. Abnormalities in normal-appearing white matter from which multiple sclerosis lesions arise. Brain Communications. 3: fcab176. PMID 34557664 DOI: 10.1093/braincomms/fcab176  0.409
2021 Arnold DL, Belachew S, Gafson AR, Gaetano L, Bernasconi C, Elliott C. Slowly expanding lesions are a marker of progressive MS - No. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211017020. PMID 34474615 DOI: 10.1177/13524585211017020  0.382
2021 Reich DS, Arnold DL, Vermersch P, Bar-Or A, Fox RJ, Matta A, Turner T, Wallström E, Zhang X, Mareš M, Khabirov FA, Traboulsee A. Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial. The Lancet. Neurology. 20: 729-738. PMID 34418400 DOI: 10.1016/S1474-4422(21)00237-4  0.306
2021 Lee H, Nakamura K, Narayanan S, Brown RA, Nash RA, Griffith LM, Steinmiller KC, Devine SM, Hutton GJ, Popat U, Racke MK, Georges GE, Bowen JD, Arnold DL. Brain volume change after high-dose immunosuppression and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 54: 103149. PMID 34284316 DOI: 10.1016/j.msard.2021.103149  0.661
2021 Campbell Cree BA, Arnold DL, Chataway J, Chitnis T, Fox RJ, Ramajo AP, Murphy N, Lassmann H. Secondary Progressive Multiple Sclerosis: New Insights. Neurology. PMID 34088878 DOI: 10.1212/WNL.0000000000012323  0.333
2021 Eshaghi A, Young AL, Wijeratne PA, Prados F, Arnold DL, Narayanan S, Guttmann CRG, Barkhof F, Alexander DC, Thompson AJ, Chard D, Ciccarelli O. Author Correction: Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data. Nature Communications. 12: 3169. PMID 34016975 DOI: 10.1038/s41467-021-23538-6  0.596
2021 Colato E, Stutters J, Tur C, Narayanan S, Arnold DL, Gandini Wheeler-Kingshott CAM, Barkhof F, Ciccarelli O, Chard DT, Eshaghi A. Predicting disability progression and cognitive worsening in multiple sclerosis using patterns of grey matter volumes. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 33879535 DOI: 10.1136/jnnp-2020-325610  0.679
2021 Eshaghi A, Young AL, Wijeratne PA, Prados F, Arnold DL, Narayanan S, Guttmann CRG, Barkhof F, Alexander DC, Thompson AJ, Chard D, Ciccarelli O. Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data. Nature Communications. 12: 2078. PMID 33824310 DOI: 10.1038/s41467-021-22265-2  0.693
2021 Ontaneda D, Raza PC, Mahajan KR, Arnold DL, Dwyer MG, Gauthier SA, Greve DN, Harrison DM, Henry RG, Li DKB, Mainero C, Moore W, Narayanan S, Oh J, Patel R, et al. Deep grey matter injury in multiple sclerosis: A NAIMS consensus statement. Brain : a Journal of Neurology. PMID 33757115 DOI: 10.1093/brain/awab132  0.653
2021 Nyirenda MH, Fadda G, Healy LM, Mexhitaj I, Poliquin-Lasnier L, Hanwell H, Saveriano AW, Rozenberg A, Li R, Moore CS, Belabani C, Johnson T, O'Mahony J, Arnold DL, Yeh EA, et al. Pro-inflammatory adiponectin in pediatric-onset multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458521989090. PMID 33522403 DOI: 10.1177/1352458521989090  0.309
2020 Kapoor R, Smith KE, Allegretta M, Arnold DL, Carroll W, Comabella M, Furlan R, Harp C, Kuhle J, Leppert D, Plavina T, Sellebjerg F, Sincock C, Teunissen CE, Topalli I, et al. Serum neurofilament light as a biomarker in progressive multiple sclerosis. Neurology. PMID 32675076 DOI: 10.1212/WNL.0000000000010346  0.344
2020 Kappos L, Wolinsky JS, Giovannoni G, Arnold DL, Wang Q, Bernasconi C, Model F, Koendgen H, Manfrini M, Belachew S, Hauser SL. Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials. Jama Neurology. PMID 32511687 DOI: 10.1001/Jamaneurol.2020.1568  0.311
2020 Thebault S, Lee H, Bose G, Tessier D, Abdoli M, Bowman M, Berard J, Walker L, Rush CA, MacLean H, Booth RA, Narayanan S, Arnold DL, Tabard-Cossa V, Atkins HL, et al. Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosis. Annals of Clinical and Translational Neurology. PMID 32304358 DOI: 10.1002/acn3.51045  0.613
2020 Dadar M, Narayanan S, Arnold DL, Collins DL, Maranzano J. Conversion of diffusely abnormal white matter to focal lesions is linked to progression in secondary progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520912172. PMID 32202199 DOI: 10.1177/1352458520912172  0.559
2020 Narayanan S, Nakamura K, Fonov VS, Maranzano J, Caramanos Z, Giacomini PS, Collins DL, Arnold DL. Brain volume loss in individuals over time: Source of variance and limits of detectability. Neuroimage. 116737. PMID 32171923 DOI: 10.1016/j.neuroimage.2020.116737  0.648
2020 Maranzano J, Dadar M, Zhernovaia M, Arnold DL, Collins DL, Narayanan S. Automated separation of diffusely abnormal white matter from focal white matter lesions on MRI in multiple sclerosis. Neuroimage. 116690. PMID 32119987 DOI: 10.1016/j.neuroimage.2020.116690  0.559
2019 Nair T, Precup D, Arnold DL, Arbel T. Exploring uncertainty measures in deep networks for Multiple sclerosis lesion detection and segmentation. Medical Image Analysis. 59: 101557. PMID 31677438 DOI: 10.1016/J.Media.2019.101557  0.346
2019 Elliott C, Belachew S, Wolinsky JS, Hauser SL, Kappos L, Barkhof F, Bernasconi C, Fecker J, Model F, Wei W, Arnold DL. Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis. Brain : a Journal of Neurology. 142: 2787-2799. PMID 31497864 DOI: 10.1093/Brain/Awz212  0.355
2019 Bells S, Lefebvre J, Longoni G, Narayanan S, Arnold DL, Yeh EA, Mabbott DJ. White matter plasticity and maturation in human cognition. Glia. PMID 31233643 DOI: 10.1002/Glia.23661  0.613
2019 Oh J, Ontaneda D, Azevedo C, Klawiter EC, Absinta M, Arnold DL, Bakshi R, Calabresi PA, Crainiceanu C, Dewey B, Freeman L, Gauthier S, Henry R, Inglese M, Kolind S, et al. Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS. Neurology. PMID 30787160 DOI: 10.1212/Wnl.0000000000007099  0.637
2018 Elliott C, Wolinsky JS, Hauser SL, Kappos L, Barkhof F, Bernasconi C, Wei W, Belachew S, Arnold DL. Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518814117. PMID 30566027 DOI: 10.1177/1352458518814117  0.4
2018 Lee H, Nakamura K, Narayanan S, Brown RA, Arnold DL. Estimating and accounting for the effect of MRI scanner changes on longitudinal whole-brain volume change measurements. Neuroimage. PMID 30253207 DOI: 10.1016/J.Neuroimage.2018.09.062  0.599
2018 Nakamura K, Eskildsen SF, Narayanan S, Arnold DL, Collins DL. Improving the SIENA performance using BEaST brain extraction. Plos One. 13: e0196945. PMID 30235215 DOI: 10.1371/journal.pone.0196945  0.559
2018 Longoni G, Brown RA, Aubert-Broche B, Grover SA, Branson HM, Fetco D, Bar-Or A, Marrie RA, Motl RW, Collins DL, Narayanan S, Arnold DL, Banwell B, Yeh EA. Physical activity and dentate gyrus volume in pediatric acquired demyelinating syndromes. Neurology(R) Neuroimmunology & Neuroinflammation. 5: e499. PMID 30211252 DOI: 10.1212/Nxi.0000000000000499  0.594
2018 Fadda G, Brown RA, Longoni G, Castro DA, O'Mahony J, Verhey LH, Branson HM, Waters P, Bar-Or A, Marrie RA, Yeh EA, Narayanan S, Arnold DL, Banwell B. MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study. The Lancet. Child & Adolescent Health. 2: 191-204. PMID 30169254 DOI: 10.1016/S2352-4642(18)30026-9  0.654
2018 Maranzano J, Till C, Assemlal HE, Fonov V, Brown R, Araujo D, O'Mahony J, Yeh EA, Bar-Or A, Marrie RA, Collins L, Banwell B, Arnold DL, Narayanan S. Detection and clinical correlation of leukocortical lesions in pediatric-onset multiple sclerosis on multi-contrast MRI. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518779952. PMID 29852831 DOI: 10.1177/1352458518779952  0.685
2018 Havrdová E, Arnold DL, Bar-Or A, Comi G, Hartung HP, Kappos L, Lublin F, Selmaj K, Traboulsee A, Belachew S, Bennett I, Buffels R, Garren H, Han J, Julian L, et al. No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 4: 2055217318760642. PMID 29568544 DOI: 10.1177/2055217318760642  0.364
2018 Kapoor R, Ho PR, Campbell N, Chang I, Deykin A, Forrestal F, Lucas N, Yu B, Arnold DL, Freedman MS, Goldman MD, Hartung HP, Havrdová EK, Jeffery D, Miller A, et al. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension. The Lancet. Neurology. PMID 29545067 DOI: 10.1016/S1474-4422(18)30069-3  0.323
2017 Maranzano J, Rudko DA, Nakamura K, Cook S, Cadavid D, Wolansky L, Arnold DL, Narayanan S. MRI evidence of acute inflammation in leukocortical lesions of patients with early multiple sclerosis. Neurology. PMID 28724581 DOI: 10.1212/Wnl.0000000000004227  0.816
2017 Lee H, Nakamura K, Narayanan S, Brown R, Chen J, Atkins HL, Freedman MS, Arnold DL. Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517715811. PMID 28617152 DOI: 10.1177/1352458517715811  0.669
2017 Aubert-Broche B, Weier K, Longoni G, Fonov VS, Bar-Or A, Marrie RA, Yeh EA, Narayanan S, Arnold DL, Verhey LH, Banwell B, Collins DL. Monophasic demyelination reduces brain growth in children. Neurology. PMID 28381515 DOI: 10.1212/Wnl.0000000000003884  0.599
2017 Longoni G, Brown RA, MomayyezSiahkal P, Elliott C, Narayanan S, Bar-Or A, Ann Marrie R, Ann Yeh E, Filippi M, Banwell B, Arnold DL. White matter changes in paediatric multiple sclerosis and monophasic demyelinating disorders. Brain : a Journal of Neurology. PMID 28334875 DOI: 10.1093/Brain/Awx041  0.676
2017 Arnold DL, Calabresi PA, Kieseier BC, Liu S, You X, Fiore D, Hung S. Peginterferon beta-1a improves MRI measures and increases the proportion of patients with no evidence of disease activity in relapsing-remitting multiple sclerosis: 2-year results from the ADVANCE randomized controlled trial. Bmc Neurology. 17: 29. PMID 28183276 DOI: 10.1186/S12883-017-0799-0  0.364
2017 Nantes JC, Zhong J, Holmes SA, Whatley B, Narayanan S, Lapierre Y, Arnold DL, Koski L. Corrigendum to "Intracortical inhibition abnormality during the remission phase of multiple sclerosis is related to upper limb dexterity and lesions" [Clin. Neurophysiol. 127 (2016) 1503-1511]. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. PMID 28073643 DOI: 10.1016/j.clinph.2016.11.022  0.65
2016 Till C, Noguera A, Verhey LH, O'Mahony J, Yeh EA, Mah JK, Sinopoli KJ, Brooks BL, Aubert-Broche B, Collins DL, Narayanan S, Arnold DL, Banwell BL. Cognitive and Behavioral Functioning in Childhood Acquired Demyelinating Syndromes. Journal of the International Neuropsychological Society : Jins. 22: 1050-1060. PMID 27903328 DOI: 10.1017/S1355617716000308  0.643
2016 Schwartzbach CJ, Grove RA, Brown R, Tompson D, Then Bergh F, Arnold DL. Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study. Journal of Neurology. PMID 27888416 DOI: 10.1007/s00415-016-8341-7  0.378
2016 Rudko DA, Derakhshan M, Maranzano J, Nakamura K, Arnold DL, Narayanan S. Delineation of cortical pathology in multiple sclerosis using multi-surface magnetization transfer ratio imaging. Neuroimage. Clinical. 12: 858-868. PMID 27872808 DOI: 10.1016/j.nicl.2016.10.010  0.751
2016 Banwell B, Arnold DL, Tillema JM, Rocca MA, Filippi M, Weinstock-Guttman B, Zivadinov R, Sormani MP. MRI in the evaluation of pediatric multiple sclerosis. Neurology. 87: S88-96. PMID 27572868 DOI: 10.1212/Wnl.0000000000002787  0.451
2016 Brown RA, Narayanan S, Stikov N, Cook S, Cadavid D, Wolansky L, Arnold DL. MTR recovery in brain lesions in the BECOME study of glatiramer acetate vs interferon β-1b. Neurology. PMID 27473139 DOI: 10.1212/Wnl.0000000000003043  0.672
2016 Lee H, Narayanan S, Brown RA, Chen JT, Atkins HL, Freedman MS, Arnold DL. Brain atrophy after bone marrow transplantation for treatment of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27246142 DOI: 10.1177/1352458516650992  0.631
2015 Arnold DL, Li D, Hohol M, Chakraborty S, Chankowsky J, Alikhani K, Duquette P, Bhan V, Montanera W, Rabinovitch H, Morrish W, Vandorpe R, Guilbert F, Traboulsee A, Kremenchutzky M. Evolving role of MRI in optimizing the treatment of multiple sclerosis: Canadian Consensus recommendations. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 1: 2055217315589775. PMID 28607695 DOI: 10.1177/2055217315589775  0.317
2015 Guizard N, Nakamura K, Coupé P, Fonov VS, Arnold DL, Collins DL. Non-Local Means Inpainting of MS Lesions in Longitudinal Image Processing. Frontiers in Neuroscience. 9: 456. PMID 26696815 DOI: 10.3389/fnins.2015.00456  0.399
2015 Weier K, Fonov V, Aubert-Broche B, Arnold DL, Banwell B, Collins DL. Impaired growth of the cerebellum in pediatric-onset acquired CNS demyelinating disease. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26552732 DOI: 10.1177/1352458515615224  0.339
2015 Nantes JC, Zhong J, Holmes SA, Whatley B, Narayanan S, Lapierre Y, Arnold DL, Koski L. Intracortical inhibition abnormality during the remission phase of multiple sclerosis is related to upper limb dexterity and lesions. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. PMID 26394909 DOI: 10.1016/j.clinph.2015.08.011  0.642
2015 Akbar N, Till C, Sled JG, Binns MA, Doesburg SM, Aubert-Broche B, Collins DL, Araujo D, Narayanan S, Arnold DL, Lysenko M, Banwell B. Altered resting-state functional connectivity in cognitively preserved pediatric-onset MS patients and relationship to structural damage and cognitive performance. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26362891 DOI: 10.1177/1352458515602336  0.62
2015 Subbanna N, Precup D, Arnold D, Arbel T. IMaGe: Iterative Multilevel Probabilistic Graphical Model for Detection and Segmentation of Multiple Sclerosis Lesions in Brain MRI. Information Processing in Medical Imaging : Proceedings of the ... Conference. 24: 514-26. PMID 26221699  0.373
2015 Weier K, Till C, Fonov V, Yeh EA, Arnold DL, Banwell B, Collins DL. Contribution of the cerebellum to cognitive performance in children and adolescents with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26203072 DOI: 10.1177/1352458515595132  0.352
2015 Guizard N, Coupé P, Fonov VS, Manjón JV, Arnold DL, Collins DL. Rotation-invariant multi-contrast non-local means for MS lesion segmentation. Neuroimage. Clinical. 8: 376-89. PMID 26106563 DOI: 10.1016/j.nicl.2015.05.001  0.325
2015 Nakamura K, Brown RA, Narayanan S, Collins DL, Arnold DL. Diurnal fluctuations in brain volume: Statistical analyses of MRI from large populations. Neuroimage. 118: 126-132. PMID 26049148 DOI: 10.1016/J.Neuroimage.2015.05.077  0.646
2015 De Stefano N, Arnold DL. Towards a better understanding of pseudoatrophy in the brain of multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 675-6. PMID 25623248 DOI: 10.1177/1352458514564494  0.313
2015 Harmouche R, Subbanna NK, Collins DL, Arnold DL, Arbel T. Probabilistic multiple sclerosis lesion classification based on modeling regional intensity variability and local neighborhood information. Ieee Transactions On Bio-Medical Engineering. 62: 1281-92. PMID 25546852 DOI: 10.1109/Tbme.2014.2385635  0.358
2015 Ghassemi R, Brown R, Banwell B, Narayanan S, Arnold DL. Quantitative Measurement of tissue damage and recovery within new T2w lesions in pediatric- and adult-onset multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 718-25. PMID 25480858 DOI: 10.1177/1352458514551594  0.658
2015 Ghassemi R, Brown R, Narayanan S, Banwell B, Nakamura K, Arnold DL. Normalization of white matter intensity on T1-weighted images of patients with acquired central nervous system demyelination. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 25: 184-90. PMID 24942347 DOI: 10.1111/Jon.12129  0.689
2014 Brown RA, Narayanan S, Arnold DL. Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis. Neuroimage. Clinical. 6: 20-5. PMID 25610760 DOI: 10.1016/J.Nicl.2014.06.009  0.703
2014 Karimaghaloo Z, Rivaz H, Collins DL, Arnold DL, Arbel T. Temporal Hierarchical Adaptive Texture CRF for Automatic Detection of Gadolinium-Enhancing Multiple Sclerosis Lesions in Brain MRI. Ieee Transactions On Medical Imaging. PMID 25532171 DOI: 10.1109/Tmi.2014.2382561  0.314
2014 Quintana FJ, Patel B, Yeste A, Nyirenda M, Kenison J, Rahbari R, Fetco D, Hussain M, O'Mahony J, Magalhaes S, McGowan M, Johnson T, Rajasekharan S, Narayanan S, Arnold DL, et al. Epitope spreading as an early pathogenic event in pediatric multiple sclerosis. Neurology. 83: 2219-26. PMID 25381299 DOI: 10.1212/Wnl.0000000000001066  0.648
2014 Brown RA, Narayanan S, Banwell B, Arnold DL. Magnetization transfer ratio recovery in new lesions decreases during adolescence in pediatric-onset multiple sclerosis patients. Neuroimage. Clinical. 6: 237-42. PMID 25379436 DOI: 10.1016/J.Nicl.2014.09.003  0.676
2014 Nakamura K, Brown RA, Araujo D, Narayanan S, Arnold DL. Correlation between brain volume change and T2 relaxation time induced by dehydration and rehydration: implications for monitoring atrophy in clinical studies. Neuroimage. Clinical. 6: 166-70. PMID 25379428 DOI: 10.1016/J.Nicl.2014.08.014  0.615
2014 Aubert-Broche B, Fonov V, Narayanan S, Arnold DL, Araujo D, Fetco D, Till C, Sled JG, Banwell B, Collins DL. Onset of multiple sclerosis before adulthood leads to failure of age-expected brain growth. Neurology. 83: 2140-6. PMID 25378667 DOI: 10.1212/Wnl.0000000000001045  0.647
2014 Arnold DL, Gold R, Kappos L, Bar-Or A, Giovannoni G, Selmaj K, Yang M, Zhang R, Stephan M, Sheikh SI, Dawson KT. Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study. Journal of Neurology. 261: 1794-802. PMID 24989666 DOI: 10.1007/S00415-014-7412-X  0.304
2014 Ghassemi R, Narayanan S, Banwell B, Sled JG, Shroff M, Arnold DL. Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis. Plos One. 9: e85741. PMID 24586244 DOI: 10.1371/Journal.Pone.0085741  0.689
2014 Derakhshan M, Caramanos Z, Narayanan S, Arnold DL, Louis Collins D. Surface-based analysis reveals regions of reduced cortical magnetization transfer ratio in patients with multiple sclerosis: a proposed method for imaging subpial demyelination. Human Brain Mapping. 35: 3402-13. PMID 24356893 DOI: 10.1002/hbm.22410  0.628
2014 Nakamura K, Guizard N, Fonov VS, Narayanan S, Collins DL, Arnold DL. Jacobian integration method increases the statistical power to measure gray matter atrophy in multiple sclerosis. Neuroimage. Clinical. 4: 10-7. PMID 24266007 DOI: 10.1016/j.nicl.2013.10.015  0.622
2014 Trojan DA, Narayanan S, Francis SJ, Caramanos Z, Robinson A, Cardoso M, Arnold DL. Brain volume and fatigue in patients with postpoliomyelitis syndrome. Pm & R : the Journal of Injury, Function, and Rehabilitation. 6: 215-20. PMID 24060387 DOI: 10.1016/j.pmrj.2013.09.009  0.596
2013 Karimaghaloo Z, Rivaz H, Arnold DL, Collins DL, Arbel T. Adaptive voxel, texture and temporal conditional random fields for detection of Gad-enhancing multiple sclerosis lesions in brain MRI. Medical Image Computing and Computer-Assisted Intervention : Miccai ... International Conference On Medical Image Computing and Computer-Assisted Intervention. 16: 543-50. PMID 24505804 DOI: 10.1007/978-3-642-40760-4_68  0.395
2013 Verhey LH, Signori A, Arnold DL, Bar-Or A, Sadovnick AD, Marrie RA, Banwell B, Sormani MP. Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials. Neurology. 81: 1215-21. PMID 23966255 DOI: 10.1212/Wnl.0B013E3182A6Cb9B  0.333
2013 Elliott C, Arnold DL, Collins DL, Arbel T. Temporally consistent probabilistic detection of new multiple sclerosis lesions in brain MRI. Ieee Transactions On Medical Imaging. 32: 1490-503. PMID 23613032 DOI: 10.1109/Tmi.2013.2258403  0.37
2013 Arnold DL, Narayanan S, Antel S. Neuroprotection with glatiramer acetate: evidence from the PreCISe trial. Journal of Neurology. 260: 1901-6. PMID 23589190 DOI: 10.1007/s00415-013-6903-5  0.528
2013 Till C, Racine N, Araujo D, Narayanan S, Collins DL, Aubert-Broche B, Arnold DL, Banwell B. Changes in cognitive performance over a 1-year period in children and adolescents with multiple sclerosis. Neuropsychology. 27: 210-9. PMID 23527649 DOI: 10.1037/A0031665  0.632
2013 Chen JT, Easley K, Schneider C, Nakamura K, Kidd GJ, Chang A, Staugaitis SM, Fox RJ, Fisher E, Arnold DL, Trapp BD. Clinically feasible MTR is sensitive to cortical demyelination in MS. Neurology. 80: 246-52. PMID 23269598 DOI: 10.1212/Wnl.0B013E31827Deb99  0.356
2013 Brown RA, Narayanan S, Arnold DL. Segmentation of magnetization transfer ratio lesions for longitudinal analysis of demyelination and remyelination in multiple sclerosis. Neuroimage. 66: 103-9. PMID 23110887 DOI: 10.1016/J.Neuroimage.2012.10.059  0.669
2013 García-Lorenzo D, Francis S, Narayanan S, Arnold DL, Collins DL. Review of automatic segmentation methods of multiple sclerosis white matter lesions on conventional magnetic resonance imaging. Medical Image Analysis. 17: 1-18. PMID 23084503 DOI: 10.1016/j.media.2012.09.004  0.668
2012 Karimaghaloo Z, Arnold DL, Collins DL, Arbel T. Hierarchical conditional random fields for detection of gad-enhancing lesions in multiple sclerosis. Medical Image Computing and Computer-Assisted Intervention : Miccai ... International Conference On Medical Image Computing and Computer-Assisted Intervention. 15: 379-86. PMID 23286071  0.388
2012 Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. The New England Journal of Medicine. 367: 1098-107. PMID 22992073 DOI: 10.1056/Nejmoa1114287  0.348
2012 Sadaka Y, Verhey LH, Shroff MM, Branson HM, Arnold DL, Narayanan S, Sled JG, Bar-Or A, Sadovnick AD, McGowan M, Marrie RA, Banwell B. 2010 McDonald criteria for diagnosing pediatric multiple sclerosis. Annals of Neurology. 72: 211-23. PMID 22926854 DOI: 10.1002/Ana.23575  0.678
2012 Fuentes A, Collins DL, Garcia-Lorenzo D, Sled JG, Narayanan S, Arnold DL, Banwell BL, Till C. Memory performance and normalized regional brain volumes in patients with pediatric-onset multiple sclerosis. Journal of the International Neuropsychological Society : Jins. 18: 471-80. PMID 22321690 DOI: 10.1017/S1355617711001913  0.631
2012 Karimaghaloo Z, Shah M, Francis SJ, Arnold DL, Collins DL, Arbel T. Automatic detection of gadolinium-enhancing multiple sclerosis lesions in brain MRI using conditional random fields. Ieee Transactions On Medical Imaging. 31: 1181-94. PMID 22318484 DOI: 10.1109/Tmi.2012.2186639  0.389
2012 Caramanos Z, Francis SJ, Narayanan S, Lapierre Y, Arnold DL. Large, nonplateauing relationship between clinical disability and cerebral white matter lesion load in patients with multiple sclerosis. Archives of Neurology. 69: 89-95. PMID 22232348 DOI: 10.1001/archneurol.2011.765  0.68
2011 Verhey LH, Branson HM, Shroff MM, Callen DJ, Sled JG, Narayanan S, Sadovnick AD, Bar-Or A, Arnold DL, Marrie RA, Banwell B. MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study. The Lancet. Neurology. 10: 1065-73. PMID 22067635 DOI: 10.1016/S1474-4422(11)70250-2  0.679
2011 Banwell B, Bar-Or A, Arnold DL, Sadovnick D, Narayanan S, McGowan M, O'Mahony J, Magalhaes S, Hanwell H, Vieth R, Tellier R, Vincent T, Disanto G, Ebers G, Wambera K, et al. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. The Lancet. Neurology. 10: 436-45. PMID 21459044 DOI: 10.1016/S1474-4422(11)70045-X  0.664
2011 García-Lorenzo D, Prima S, Arnold DL, Collins DL, Barillot C. Trimmed-likelihood estimation for focal lesions and tissue segmentation in multisequence MRI for multiple sclerosis. Ieee Transactions On Medical Imaging. 30: 1455-67. PMID 21324773 DOI: 10.1109/TMI.2011.2114671  0.376
2011 Shah M, Xiao Y, Subbanna N, Francis S, Arnold DL, Collins DL, Arbel T. Evaluating intensity normalization on MRIs of human brain with multiple sclerosis. Medical Image Analysis. 15: 267-82. PMID 21233004 DOI: 10.1016/J.Media.2010.12.003  0.303
2010 Karimaghaloo Z, Shah M, Francis SJ, Arnold DL, Collins DL, Arbel T. Detection of Gad-enhancing lesions in multiple sclerosis using conditional random fields. Medical Image Computing and Computer-Assisted Intervention : Miccai ... International Conference On Medical Image Computing and Computer-Assisted Intervention. 13: 41-8. PMID 20879381  0.357
2010 Elliott C, Francis SJ, Arnold DL, Collins DL, Arbel T. Bayesian classification of multiple sclerosis lesions in longitudinal MRI using subtraction images. Medical Image Computing and Computer-Assisted Intervention : Miccai ... International Conference On Medical Image Computing and Computer-Assisted Intervention. 13: 290-7. PMID 20879327  0.441
2010 Levesque IR, Sled JG, Narayanan S, Giacomini PS, Ribeiro LT, Arnold DL, Pike GB. Reproducibility of quantitative magnetization-transfer imaging parameters from repeated measurements. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 64: 391-400. PMID 20665783 DOI: 10.1002/Mrm.22350  0.586
2010 Derakhshan M, Caramanos Z, Giacomini PS, Narayanan S, Maranzano J, Francis SJ, Arnold DL, Collins DL. Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis Neuroimage. 52: 1261-1267. PMID 20483380 DOI: 10.1016/j.neuroimage.2010.05.029  0.652
2010 Caramanos Z, Fonov VS, Francis SJ, Narayanan S, Pike GB, Collins DL, Arnold DL. Gradient distortions in MRI: characterizing and correcting for their effects on SIENA-generated measures of brain volume change. Neuroimage. 49: 1601-11. PMID 19682586 DOI: 10.1016/J.Neuroimage.2009.08.008  0.631
2009 Trojan DA, Arnold DL, Shapiro S, Bar-Or A, Robinson A, Le Cruguel JP, Narayanan S, Tartaglia MC, Caramanos Z, Da Costa D. Fatigue in post-poliomyelitis syndrome: association with disease-related, behavioral, and psychosocial factors. Pm & R : the Journal of Injury, Function, and Rehabilitation. 1: 442-9. PMID 19627931 DOI: 10.1016/J.Pmrj.2009.03.003  0.549
2009 Giacomini PS, Levesque IR, Ribeiro L, Narayanan S, Francis SJ, Pike GB, Arnold DL. Measuring demyelination and remyelination in acute multiple sclerosis lesion voxels. Archives of Neurology. 66: 375-81. PMID 19273757 DOI: 10.1001/Archneurol.2008.578  0.692
2009 Caramanos Z, DiMaio S, Narayanan S, Lapierre Y, Arnold DL. 1H-MRSI evidence for cortical gray matter pathology that is independent of cerebral white matter lesion load in patients with secondary progressive multiple sclerosis Journal of the Neurological Sciences. 282: 72-79. PMID 19232641 DOI: 10.1016/j.jns.2009.01.015  0.644
2008 Giacomini PS, Arnold DL. Non-conventional MRI techniques for measuring neuroprotection, repair and plasticity in multiple sclerosis Current Opinion in Neurology. 21: 272-277. PMID 18451709 DOI: 10.1097/WCO.0b013e328300525b  0.359
2008 Ghassemi R, Antel SB, Narayanan S, Francis SJ, Bar-Or A, Sadovnick AD, Banwell B, Arnold DL. Lesion distribution in children with clinically isolated syndromes. Annals of Neurology. 63: 401-5. PMID 18306242 DOI: 10.1002/Ana.21322  0.688
2008 Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ, Bar-Or A, Panzara M, Sarkar N, Agarwal S, Langer-Gould A, Smith CH. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. The New England Journal of Medicine. 358: 676-88. PMID 18272891 DOI: 10.1056/Nejmoa0706383  0.326
2008 Chen JT, Collins DL, Atkins HL, Freedman MS, Arnold DL. Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions. Annals of Neurology. 63: 254-62. PMID 18257039 DOI: 10.1002/ana.21302  0.438
2007 Bar-Or A, Vollmer T, Antel J, Arnold DL, Bodner CA, Campagnolo D, Gianettoni J, Jalili F, Kachuck N, Lapierre Y, Niino M, Oger J, Price M, Rhodes S, Robinson WH, et al. Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial. Archives of Neurology. 64: 1407-15. PMID 17698695 DOI: 10.1001/Archneur.64.10.Nct70002  0.332
2007 Arnold DL. The place of MRI in monitoring the individual MS patient Journal of the Neurological Sciences. 259: 123-127. PMID 17376485 DOI: 10.1016/j.jns.2006.11.023  0.369
2006 Tartaglia MC, Arnold DL. The role of MRS and fMRI in multiple sclerosis Advances in Neurology. 98: 185-202. PMID 16400835  0.395
2006 Narayanan S, Francis SJ, Sled JG, Santos AC, Antel S, Levesque I, Brass S, Lapierre Y, Sappey-Marinier D, Pike GB, Arnold DL. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter. Neuroimage. 29: 637-42. PMID 16126413 DOI: 10.1016/J.Neuroimage.2005.07.017  0.678
2005 Arnold DL. Changes observed in multiple sclerosis using magnetic resonance imaging reflect a focal pathology distributed along axonal pathways Journal of Neurology. 252. PMID 16254698 DOI: 10.1007/s00415-005-5005-4  0.42
2005 Caramanos Z, Narayanan S, Arnold DL. 1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: A meta-analytic review Brain. 128: 2483-2506. PMID 16230321 DOI: 10.1093/brain/awh640  0.651
2005 Filippi M, Falini A, Arnold DL, Fazekas F, Gonen O, Simon JH, Dousset V, Savoiardo M, Wolinsky JS. Magnetic resonance techniques for the in vivo assessment of multiple sclerosis pathology: consensus report of the white matter study group. Journal of Magnetic Resonance Imaging : Jmri. 21: 669-75. PMID 15906322 DOI: 10.1002/Jmri.20336  0.376
2005 Biernacki K, Antel JP, Blain M, Narayanan S, Arnold DL, Prat A. Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis. Archives of Neurology. 62: 563-8. PMID 15824253 DOI: 10.1001/Archneur.62.4.563  0.66
2005 Levesque I, Sled JG, Narayanan S, Santos AC, Brass SD, Francis SJ, Arnold DL, Pike GB. The role of edema and demyelination in chronic T1 black holes: a quantitative magnetization transfer study. Journal of Magnetic Resonance Imaging : Jmri. 21: 103-10. PMID 15666408 DOI: 10.1002/Jmri.20231  0.62
2004 Brass SD, Narayanan S, Antel JP, Lapierre Y, Collins L, Arnold DL. Axonal damage in multiple sclerosis patients with high versus low expanded disability status scale score. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 31: 225-8. PMID 15198448 DOI: 10.1017/S0317167100053877  0.64
2004 Tartaglia MC, Narayanan S, Francis SJ, Santos AC, De Stefano N, Lapierre Y, Arnold DL. The relationship between diffuse axonal damage and fatigue in multiple sclerosis. Archives of Neurology. 61: 201-7. PMID 14967766 DOI: 10.1001/archneur.61.2.201  0.559
2003 Antel SB, Collins DL, Bernasconi N, Andermann F, Shinghal R, Kearney RE, Arnold DL, Bernasconi A. Automated detection of focal cortical dysplasia lesions using computational models of their MRI characteristics and texture analysis. Neuroimage. 19: 1748-59. PMID 12948729 DOI: 10.1016/S1053-8119(03)00226-X  0.322
2003 Laule C, Vavasour IM, Whittall KP, Oger J, Paty DW, Li DK, MacKay AL, Arnold DL. Evolution of focal and diffuse magnetisation transfer abnormalities in multiple sclerosis. Journal of Neurology. 250: 924-31. PMID 12928910 DOI: 10.1007/S00415-003-1115-Z  0.428
2002 De Stefano N, Narayanan S, Francis SJ, Smith S, Mortilla M, Tartaglia MC, Bartolozzi ML, Guidi L, Federico A, Arnold DL. Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability. Archives of Neurology. 59: 1565-71. PMID 12374493  0.646
2002 Santos AC, Narayanan S, de Stefano N, Tartaglia MC, Francis SJ, Arnaoutelis R, Caramanos Z, Antel JP, Pike GB, Arnold DL. Magnetization transfer can predict clinical evolution in patients with multiple sclerosis. Journal of Neurology. 249: 662-8. PMID 12111296 DOI: 10.1007/S00415-002-0686-4  0.688
2002 Arnold DL, Matthews PM. MRI in the diagnosis and management of multiple sclerosis. Neurology. 58: S23-31. PMID 11971123 DOI: 10.1212/Wnl.58.8_Suppl_4.S23  0.335
2002 Paty DW, Arnold DL. The lesions of multiple sclerosis. The New England Journal of Medicine. 346: 199-200. PMID 11796856 DOI: 10.1056/Nejm200201173460311  0.375
Show low-probability matches.